IPCSG Live Stream

As the enrollment period for Social Security nears, Richard Russell, a licensed sales agent will be discussing Social Security and supplemental plans.

Richard will focus on Medicare enrollment, what each of the parts A, B, C & D mean, the differences between only having original Medicare verses private insurance plans, and when it makes the most sense to compliment/supplement Original Medicare. 

He will also discuss options people have, when to make changes and why.  Another important topic, special election periods, what and when they are.

Please note, Richard can answer general questions as to the presentation and other items that may come to mind.  If Richard feel it is private in nature he will defer to contacting him directly for the answer.

Three of IPCS’s members tell of their journey with Prostate Cancer. 

Gene Van Vleet – Welcome message and overview of IPCSG’s mission. Gene will then discuss his personal journey with Prostate Cancer, how it was detected and his decisions about treatment. 

Dick Howard –  He was under the care of an oncologist late last year. A biopsy was done, but complications occurred. A very scary time for Dick. He talks about his journey from the biopsy to how he found IPCSG, and how IPCSG helped him become his own case manager! 

Ralph Hughes - His journey started in May 2014 PSA 3.95 and rising. Following a Biopsy, he had a proctectomy, but as many of us have experienced, he had a Recurrence. Ralph shares several valuable lessons he learned along his journey.

This IPCSG webinar was presented live over the internet using "ZOOM" software.  The presentations were recorded and are available on Youtube in the link to the right.

Dr. Irwin Goldstein, MD, Director of San Diego Sexual Medicine will speak about some of the negative side effects of prostate cancer treatment and their management, including urinary incontinence and erectile dysfunction.  He will also discuss contemporary research in these areas.

 Dr. Andrew Goldstein, PhD Professor-in-Residence of Urology, David Geffen School of Medicine at UCLA will explain how healthy prostate cells develop into cancer, and how prostate cancer cells develop resistance to therapy, which is critical for improving disease diagnosis and identifying new treatment options. He will present some of his laboratory's basic science research that will enable us to better understand prostate cancer biology and may lead to new approaches for therapy in the future.